CELLULO
Live / Allowed — Notice of allowance issued (as of 04 Jun 2024)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 23 Sept 2022 filing date already counts against anyone who files later.
Record
- Serial number
- 97604624
- Mark type
- Stylized text
- Filed
- 23 Sept 2022
- Published for opposition
- 09 Apr 2024
- Attorney of record
- CLINTON H WILKINSON
Goods and services
- Class 001 — Chemicals: Collagen preparations for use in the manufacture of cosmetics, nutritional supplements, and pharmaceutical preparations
- Class 003 — Cosmetics and cleaning preparations: Collagen for use as a chemical carrier for cosmetic purposes; Collagen preparations for cosmetic purposes
- Class 005 — Pharmaceuticals: Collagen for medical purposes; Pharmaceutical preparations, namely, collagen for wound and tissue treatment and care, dental purposes, and the treatment of arthritis; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Dietary and nutritional supplements containing collagen; Collagen for use as a dietary or nutritional supplement
Owner
- The Hymed Group Corporation, Bethlehem, PA, US
- The Hymed Group Corporation, Bethlehem, PA, US
Prosecution history
- 29 Jan 2026 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 29 Nov 2024 — TEAS STATEMENT OF USE RECEIVED
- 09 Oct 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 Jun 2024 — TEAS REQUEST TO DIVIDE RECEIVED
- 04 Jun 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 24 Apr 2024 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 09 Apr 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Apr 2024 — PUBLISHED FOR OPPOSITION
- 20 Mar 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Feb 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Feb 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 29 Feb 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 29 Feb 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 21 Nov 2023 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 21 Nov 2023 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED